Nek4 status differentially alters sensitivity to distinct microtubule poisons.

Cancer Research
Jason Doles, Michael T Hemann

Abstract

Microtubule poisons are widely used in cancer treatment, but the factors determining the relative efficacy of different drugs in this class remain obscure. In this study, we identified the NIMA kinase Nek4 in a genetic screen for mediators of the response to Taxol, a chemotherapeutic agent that stabilizes microtubules. After Taxol treatment, Nek4 promoted microtubule outgrowth, whereas Nek4 deficiency impaired G(2)-M arrest and decreased formation of mitotic-like asters. In contrast, Nek4 deficiency sensitized cells to vincristine, which destabilizes microtubules. Therefore, Nek4 deficiency may either antagonize or agonize the effects of microtubule poisons, depending on how they affect microtubule polymerization. Of note, Nek4 gene maps to a commonly deleted locus in non-small cell lung cancer. Thus, Nek4 deletion in this disease may rationalize the use of particular types of microtubule poisons for lung cancer therapy.

References

Dec 1, 1975·Genetical Research·N R Morris
Mar 1, 1994·Japanese Journal of Cancer Research : Gann·S OhtaN Saijo
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·T StrobelS A Cannistra
Mar 4, 1998·Current Opinion in Cell Biology·M A Jordan, L Wilson
Jun 11, 1999·British Journal of Cancer·M KavallarisS B Horwitz
Sep 2, 1999·International Journal of Cancer. Journal International Du Cancer·M V Blagosklonny, T Fojo
Sep 6, 2000·Nature Medicine·C A SchmittS W Lowe
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·A GonçalvesM A Jordan
Oct 25, 2003·Oncogene·George A OrrSusan Band Horwitz
Apr 3, 2004·Cancer Research·Tamotsu SudoNaoto T Ueno
Oct 4, 2005·Nature Genetics·Ross A DickinsScott W Lowe
Nov 11, 2005·Journal of Cell Science·Lynne M Quarmby, Moe R Mahjoub
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·C F B KimT Jacks
Oct 13, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T Fojo, M Menefee
Aug 31, 2007·Cell Division·Laura O'reganAndrew M Fry
Nov 8, 2007·The Journal of Pharmacology and Experimental Therapeutics·Vivienna OngRichard B Lock
Jun 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Darren J BurgessMichael T Hemann
Aug 1, 2008·Current Clinical Pharmacology·Isa E L M Kuppens
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick G Morris, Monica N Fornier

❮ Previous
Next ❯

Citations

Dec 24, 2013·Nature Cell Biology·Morvarid MohseniFernando D Camargo
Sep 22, 2011·Human Molecular Genetics·Milica GakovicAlan F Wright
Nov 2, 2011·Cell Division·Larissa MonizVuk Stambolic
Jan 16, 2013·PloS One·Jessica M EsparzaSusan K Dutcher
Nov 21, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Justin R PritchardMichael T Hemann
Jan 15, 2013·Biochimica Et Biophysica Acta·Sivan CohenBenny Motro
Sep 25, 2018·Journal of Cellular and Molecular Medicine·Nian-Hua DingLun-Quan Sun
Jun 28, 2014·International Journal of Oncology·Xia LiuFuqiang Yin
Apr 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Andressa Peres de OliveiraJörg Kobarg
Aug 16, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Russell MoserEduardo Méndez
Mar 7, 2021·Cells·Isadora Carolina Betim PavanJörg Kobarg
Dec 10, 2016·Journal of Proteome Research·Ritin SharmaJohn M Koomen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.